These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21375490)

  • 21. Tumor microenvironment and RIG-I signaling molecules in Epstein Barr virus-positive and -negative classical Hodgkin lymphoma of the elderly.
    Satoh T; Wada R; Yajima N; Imaizumi T; Yagihashi S
    J Clin Exp Hematop; 2014; 54(1):75-84. PubMed ID: 24942949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells.
    Emmerich F; Theurich S; Hummel M; Haeffker A; Vry MS; Döhner K; Bommert K; Stein H; Dörken B
    J Pathol; 2003 Nov; 201(3):413-20. PubMed ID: 14595753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed/Sternberg cells.
    Stanelle J; Döring C; Hansmann ML; Küppers R
    Blood; 2010 Nov; 116(20):4202-11. PubMed ID: 20660789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of NF-kappaB expression in Hodgkin's disease: inhibition of constitutively expressed NF-kappaB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells.
    Izban KF; Ergin M; Huang Q; Qin JZ; Martinez RL; Schnitzer B; Ni H; Nickoloff BJ; Alkan S
    Mod Pathol; 2001 Apr; 14(4):297-310. PubMed ID: 11301346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical assessment of the diagnostic utility of PD-L1: a preliminary analysis of anti-PD-L1 antibody (SP142) for lymphoproliferative diseases with tumour and non-malignant Hodgkin-Reed-Sternberg (HRS)-like cells.
    Sakakibara A; Kohno K; Eladl AE; Klaisuwan T; Ishikawa E; Suzuki Y; Shimada S; Nakaguro M; Shimoyama Y; Takahara T; Kato S; Asano N; Nakamura S; Satou A
    Histopathology; 2018 Jun; 72(7):1156-1163. PubMed ID: 29380399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of endoplasmic reticulum stress by sorafenib and activation of NF-κB by lestaurtinib as a novel resistance mechanism in Hodgkin lymphoma cell lines.
    Holz MS; Janning A; Renné C; Gattenlöhner S; Spieker T; Bräuninger A
    Mol Cancer Ther; 2013 Feb; 12(2):173-83. PubMed ID: 23243060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular biology of Hodgkin lymphoma.
    Weniger MA; Küppers R
    Leukemia; 2021 Apr; 35(4):968-981. PubMed ID: 33686198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis.
    Mathas S; Lietz A; Anagnostopoulos I; Hummel F; Wiesner B; Janz M; Jundt F; Hirsch B; Jöhrens-Leder K; Vornlocher HP; Bommert K; Stein H; Dörken B
    J Exp Med; 2004 Apr; 199(8):1041-52. PubMed ID: 15078899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hodgkin disease: pharmacologic intervention of the CD40-NF kappa B pathway by a protease inhibitor.
    Annunziata CM; Safiran YJ; Irving SG; Kasid UN; Cossman J
    Blood; 2000 Oct; 96(8):2841-8. PubMed ID: 11023520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
    Wang E; Papavassiliou P; Sebastian S
    Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells.
    Horie R; Watanabe T; Morishita Y; Ito K; Ishida T; Kanegae Y; Saito I; Higashihara M; Mori S; Kadin ME; Watanabe T
    Oncogene; 2002 Apr; 21(16):2493-503. PubMed ID: 11971184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.
    Vockerodt M; Wei W; Nagy E; Prouzova Z; Schrader A; Kube D; Rowe M; Woodman CB; Murray PG
    J Pathol; 2013 Aug; 230(4):399-409. PubMed ID: 23592216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The molecular basis for the generation of Hodgkin and Reed-Sternberg cells in Hodgkin's lymphoma.
    Lee IS; Kim SH; Song HG; Park SH
    Int J Hematol; 2003 May; 77(4):330-5. PubMed ID: 12774919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma.
    Bohle V; Döring C; Hansmann ML; Küppers R
    Leukemia; 2013 Mar; 27(3):671-9. PubMed ID: 23174882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The biological basis of Hodgkin's lymphoma.
    Horie R; Watanabe T
    Drug News Perspect; 2003 Dec; 16(10):649-56. PubMed ID: 14747844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hodgkin lymphoma.
    Küppers R; Engert A; Hansmann ML
    J Clin Invest; 2012 Oct; 122(10):3439-47. PubMed ID: 23023715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.
    Buettner M; Greiner A; Avramidou A; Jäck HM; Niedobitek G
    Hematol Oncol; 2005; 23(3-4):127-32. PubMed ID: 16342298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells.
    Izban KF; Ergin M; Martinez RL; Alkan S
    Mod Pathol; 2000 Dec; 13(12):1324-31. PubMed ID: 11144929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma.
    Barth TF; Martin-Subero JI; Joos S; Menz CK; Hasel C; Mechtersheimer G; Parwaresch RM; Lichter P; Siebert R; Möoller P
    Blood; 2003 May; 101(9):3681-6. PubMed ID: 12511414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The molecular pathology of classical Hodgkin lymphoma].
    Asano N
    Rinsho Ketsueki; 2015 Oct; 56(10):2024-31. PubMed ID: 26458441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.